Shanghai Fosun Pharmaceutical, a leading Chinese health care provider, has signed an agreement to buy 86.08 per cent of the equity in Hyderabad-based Gland Pharma for $1.26 billion (nearly Rs 8,500 crore). This values the Indian generic injectable ... Business Standard India, 4 weeks ago
ET's weekly roundup of the wackiest whispers and murmurs in corporate corridors and policy parlours. Search Resumes Some years ago, a leading conglomerate was hit with a gust of bad publicity, thanks to its PR firm. The diversified group had to ...Economic Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!